	Despesas De Vendas E Administração		Data
Acadia Pharmaceuticals	USD 124.9M	1.24M	2025-09
Adma Biologics	USD 23.05M	320K	2025-09
ALKERMES	USD 171.77M	17.9M	2025-09
Alterity Therapeutics Limited	AUD 2.29M	649.1K	2023-06
AstraZeneca	USD 148M	4.86B	2025-09
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Cipla	INR 13.25B	101.8M	2025-12
Clal Biotechnology	ILS 3.31M	513K	2022-12
Compugen	USD 2.33M	50K	2025-09
CSL	USD 727M	453M	2025-06
Dynavax Technologies	USD 40.09M	1.45M	2025-09
Eli Lilly	USD 3.13B	391.3M	2025-12
Esperion Therapeutics	USD 39.98M	4.21M	2024-09
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Grifols	EUR 333.1M	157M	2025-09
Halozyme Therapeutics	USD 37.53M	4.53M	2025-09
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
J&J	USD 6.75B	831M	2025-12
Merck	USD 2.85B	215M	2025-12
Minerva Neurosciences	USD 2.48M	58.79K	2024-09
Neurocrine Biosciences	USD 291.6M	5.3M	2025-09
Novartis	USD 3.31B	134M	2025-09
Novavax	USD 66.95M	34.05M	2024-09
Pfizer	USD 4.08B	894M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sanofi	EUR 2.75B	455M	2025-12
Takeda	JPY 282.78B	29.23B	2025-12
Vanda Pharmaceuticals	USD 39.28M	1.71M	2024-12

Minerva Neurosciences Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.